Buscar
Mostrando ítems 1-10 de 285
EFFECTS OF CHOLINERGIC AGENTS ON RAT LIVER PLASMA MEMBRANE GUANYLATE CYCLASE
(FEBS LETTERS, 2016)
Azul de metileno no tratamento da síndrome vasoplégica em cirurgia cardíaca. quinze anos de perguntas, respostas, dúvidas e certezas
(2009-07-01)
Objective: There is strong evidence that methylene blue (MB), an inhibitor of guanylate cyclase, is an excellent therapeutic option for vasoplegic syndrome (VS) treatment in heart surgery. The aim of this article is to ...
Azul de metileno no tratamento da síndrome vasoplégica em cirurgia cardíaca. quinze anos de perguntas, respostas, dúvidas e certezas
(2009-07-01)
Objective: There is strong evidence that methylene blue (MB), an inhibitor of guanylate cyclase, is an excellent therapeutic option for vasoplegic syndrome (VS) treatment in heart surgery. The aim of this article is to ...
Pharmacological evidence that methylene blue inhibits noradrenaline neuronal uptake in the rat vas deferens
(2003-10-09)
We report that the classical guanylate cyclase inhibitor methylene blue (MB, 1 μM or 10 μM), but not the selective guanylate cyclase inhibitor 1H-[1,2,4]oxidazolo[4,3-a]quinoxalin-1-one (1 μM) or nitric oxide synthase ...
Guanylate cyclase, potassium channels and eNOS are involved in TERPY effect in resistance vessels of SHR
(Federation Amer Soc Exp Biol, 2015-04-01)